Clinical Trial Update: A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 2]

View source ↗

Summary

Phase 2 synovial biopsy trial of JNJ-38518168 in active rheumatoid arthritis patients on methotrexate was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• JNJ-38518168

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED